How do improperly primed hyporesponsive T-cells contribute to cancer, and can these cells be rescued?

Yohei Nose, Ph.D.
Post-Doctoral Fellow
Laboratory of Sacha Gnjatic
Department of Medicine, Division of Hematology and Medical Oncology

Engineering LNPs with polysarcosine lipids for mRNA delivery

Diana Kang
Ph.D. Student
Laboratory of Yizhou Dong
Department of Oncological Sciences